Expanded Access Protocol for Patients With Eosinophilic Esophagitis

Exclusion Criteria

• •1. Have known contraindication, hypersensitivity, or intolerance to corticosteroids
• •2. Have signs and symptoms of adrenal suppression or hypercorticism
• •3. Use of potent CYP3A4 inhibitors (e.g., ritonavir and ketoconazole) are prohibited
• •4. Have current alcohol or drug abuse in the opinion of the Investigator
• •5. Female patients who are pregnant, breastfeeding, or planning to become pregnant while participating in the program
• •6. Female patients of child-bearing potential who are unable to comply with adequate contraception use during the program